α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study

Prostate

Volumn 72, Issue 3, 2012, Pages 301-306

  Barry, Marc ^a,c   Dhillon, Preet K ^a,b,d   Stampfer, Meir J ^a,b   Perner, Sven ^a,e   Ma, Jing ^a   Giovannucci, Edward ^a,b   Kurth, Tobias ^a,b,f   Mucci, Lorelei A ^a,b   Rubin, Mark A ^a,g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f INSERM   (France)

^g Department of Obstetrics Gynecology   (United States)

Author keywords

AMACR; biomarker; cohort; urologic

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; FATALITY; FOLLOW UP; GLEASON SCORE; HAZARD RATIO; HEALTH CARE PERSONNEL; HEALTH PRACTITIONER; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN EXPRESSION; TISSUE SECTION; TREND STUDY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84855678907     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21432     Document Type: Article

References (13)

1. Lloyd MD, Darley DJ, Wierzbicki AS, Threadgill MD,. Alpha-methylacyl-CoA racemase-An 'obscure' metabolic enzyme takes centre stage. FEBS J 2008; 275 (6): 1089-1102. (Pubitemid 351342223)
2. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P, Reed SG, Xu J, Fanger GR,. P504S: A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001; 25 (11): 1397-1404. (Pubitemid 33022055)
3. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM,. Alpha-methylacyl CoA racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287 (13): 1662-1670. (Pubitemid 34289218)
4. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM,. Alpha-methylacyl CoA racemase: A new molecular marker for prostate cancer. Cancer Res 2002; 62 (8): 2220-2226. (Pubitemid 34411693)
5. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM,. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005; 8 (5): 393-406. (Pubitemid 41579834)
6. Zheng SL, Chang BL, Faith DA, Johnson JR, Isaacs SD, Hawkins GA, Turner A, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB, Xu J,. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res 2002; 62 (22): 6485-6488. (Pubitemid 35364112)
7. Levin AM, Zuhlke KA, Ray AM, Cooney KA, Douglas JA,. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer. Prostate 2007; 67 (14): 1506-1513.
8. Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H, Mattfeldt T, Hautmann RE, Gschwend JE, Barrette TR, Dunn RL, Chinnaiyan AM, Rubin MA,. Alpha-methylacyl CoA racemase: Expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 2002; 161 (3): 841-848. (Pubitemid 34988371)
9. Rubin MA, Bismar TA, Andren O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE,. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev 2005; 14 (6): 1424-1432. (Pubitemid 40807341)
10. Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM, Isaacs WB,. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 2003; 63 (21): 7365-7376. (Pubitemid 37413478)
11. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE,. Vitamins E and C in the prevention of prostate and total cancer in men: The Physicians' Health Study II randomized controlled trial. JAMA 2009; 301 (1): 52-62.
12. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC,. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85 (19): 1571-1579. (Pubitemid 23304685)
13. Dhillon PK, Barry M, Stampfer MJ, Perner S, Fiorentino M, Fornari A, Ma J, Fleet J, Kurth T, Rubin MA, Mucci LA,. Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 2009; 18 (2): 595-600.